Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NewSelf vs SnagRx

By GLP-1 ScorecardUpdated

NewSelf
Site position #39

Higher grade

SnagRx
Site position #353

Lower grade

Score comparison

NewSelf has the higher recorded score — 79.8/100 to 57.9/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNewSelf +57
93
36
Dose & formulationNewSelf +16
80
64
Clinical oversightSnagRx +21
55
76
Labs & monitoringNewSelf +29
82
53
FulfillmentNewSelf +16
87
71
Contract termsNewSelf +30
85
55
NewSelf · top barSnagRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNewSelfSnagRx
WeighScore79.8/10057.9/100
GradeC+C
Site position#39#353
Semaglutide$100/mo$99/mo (one-month compounded plan)
Tirzepatide$144/mo$149/mo (one-month compounded plan)
CoverageAll 50 statesFAQ excludes Louisiana; confirm state eligibility
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
NewSelf

Site position #39 · C+

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

What to consider

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history
SnagRx

Site position #353 · C

Strengths

  • One-month compounded injection plans advertised at $99 semaglutide / $149 tirzepatide
  • Three-, six- and twelve-month prepaid options with published totals
  • Terms name four possible pharmacy partners; individual assignment needs confirmation
  • Product pages advertise evaluation, medication, coaching, messaging and shipping

What to consider

  • Lowest $69/$119 monthly equivalents require $828/$1,428 twelve-month prepayments
  • Final pharmacy-related charges may vary despite flat-dose marketing
  • Refund policy makes payments final immediately; medical rejection refunds may deduct used services
  • Cancellation cutoffs differ: five days before the prescription period ends versus 72 hours before billing
  • Homepage state restrictions conflict with broader terms; confirm eligibility

Featured provider

SnagRx

SnagRx scores 57.9/100 (C). SnagRx lists one-month compounded injection plans at $99/$149, with prepaid discounts and refund rules to resolve before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard